Sparrow Pharmaceuticals
Clinical trials sponsored by Sparrow Pharmaceuticals, explained in plain language.
-
New pill targets hormone imbalance from adrenal tumors
Disease control CompletedThis study tested a daily pill called SPI-62 in 30 adults with high cortisol levels caused by a non-cancerous adrenal tumor. The goal was to see if the drug could safely lower blood sugar and improve other health measures. Participants took 2 mg of SPI-62 each day for up to 12 we…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug shows promise for cortisol disorder
Disease control CompletedThis study tested an experimental drug called SPI-62 in 26 adults with Cushing's syndrome caused by a non-adrenal tumor. The goal was to see if SPI-62 could lower cortisol levels safely. Participants received either SPI-62 or a placebo for 24 weeks, with an option to continue lon…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Healthy volunteers help test new drug's interactions
Knowledge-focused CompletedThis study looked at whether a new drug called clofutriben affects how the body handles two common medicines, midazolam and prednisolone. Sixteen healthy adults took clofutriben daily for 16 days along with single doses of the other drugs. The goal was to measure drug levels in t…
Phase: PHASE1 • Sponsor: Sparrow Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC